SCHEMBL4950423

SCHEMBL4950423

COc1ccc(CCC(C)N(Cc2ccccc2)CC(O)c2ccc(OCc3ccccc3)c(N)c2)cc1OC

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.48
KDM4E B2RXH2 2/20 0.47
CYP1A2 P05177 1/20 0.47
CYP3A4 P08684 1/20 0.47
CYP2D6 P10635 1/20 0.47
CYP2C9 P11712 1/20 0.47
BLM P54132 1/20 0.47
BCHE P06276 2/20 0.45
MEN1 O00255 2/20 0.43
KMT2A Q03164 2/20 0.43
ABCB1 P08183 3/20 0.43
ABCG2 Q9UNQ0 2/20 0.43
APP P05067 1/20 0.43
TRPM8 Q7Z2W7 1/20 0.42
ADRB2 P07550 1/20 0.41
MTNR1A P48039 1/20 0.41
MTNR1B P49286 1/20 0.41
RAF1 P04049 1/20 0.40
MAP2K1 Q02750 1/20 0.40
STAT3 P40763 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4945028 0.88 BCHE (0.48) ALDH1A1KDM4ECYP1A2CYP3A4CYP2D6
SCHEMBL4945747 0.86 ALDH1A1 (0.47) ALDH1A1KDM4ECYP1A2CYP3A4CYP2D6
SCHEMBL719263 0.83 ALDH1A1 (0.41) ALDH1A1BCHEABCB1TRPM8
SCHEMBL719264 0.83 ALDH1A1 (0.41) ALDH1A1BCHEABCB1TRPM8
SCHEMBL28019387 0.83 ALDH1A1 (0.41) ALDH1A1BCHEABCB1TRPM8
SCHEMBL11819073 0.83 ALDH1A1 (0.47) ALDH1A1KDM4EBCHEMEN1KMT2A
SCHEMBL7252041 0.83 BCHE (0.39) ALDH1A1KDM4ECYP1A2CYP2D6BCHE
SCHEMBL11810281 0.82 OPRK1 (0.41) ALDH1A1BCHETRPM8ADRB2
SCHEMBL10450119 0.81 BCHE (0.47) ALDH1A1KDM4ECYP1A2CYP2D6BCHE
Hydrochloric Acid SCHEMBL11818993 0.81 OPRD1 (0.40) ALDH1A1BCHETRPM8ADRB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1575495-A2 COMPOUNDS AND METHODS SmithKline Beecham Corporation (US) 2005-09-21 EP claimed
US-20050113580-A1 Amide compounds and methods of using the same SMITHKLINE BEECHAM CORP 2005-05-26 US claimed
WO-2003082205-A2 COMPOUNDS AND METHODS SMITHKLINE BEECHAM CORPORATION (US) 2003-10-09 WO claimed
US-7365085-B2 Compounds and methods SMITHKLINE BEECHAM CORPORATION (US) 2008-04-29 US disclosed
EP-1575495-A2 COMPOUNDS AND METHODS SmithKline Beecham Corporation (US) 2005-09-21 EP disclosed
US-20050113580-A1 Amide compounds and methods of using the same SMITHKLINE BEECHAM CORP 2005-05-26 US disclosed
WO-2003082205-A2 COMPOUNDS AND METHODS SMITHKLINE BEECHAM CORPORATION (US) 2003-10-09 WO disclosed
US-3994974-A BRONCHODILATORS YAMANOUCHI PHARMACEUTICAL CO., LTD. (JA) 1976-11-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050113580-A1 Amide compounds and methods of using the same NR1H2, NR1H3, PPARA ALDH1A1 1460/4885KDM4E 1224/4885CYP1A2 301/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.